EUVC | E384 | Health Tech Renaissance, ChatGPT Turns Two, Northvolt's Setbacks, and Cradle's AI Success with Dan Bowyer, Mads Jensen & Lomax
EUVC
AI Merger and Psychedelic Therapeutics
This chapter explores the merger between AI companies Recursion and Accenture, focusing on the challenges of drug discovery and the implications of leadership changes. It also dives into the evolving psychedelics industry, discussing recent clinical trials and societal perceptions of these substances as potential mental health treatments. The conversation concludes on a positive note with Cradle Buyer's successful fundraising, showcasing opportunities in Europe’s health tech sector.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
